眼内敷贴放疗后同侧眼睑疾病:回顾性队列研究
该回顾性队列研究纳入2009至2023年间单中心接受巩膜敷贴放疗的191例葡萄膜黑色素瘤患者,评估同侧获得性眼睑疾病(IEDs)的患病率、特征及危险因素。结果显示IEDs发生率为20.9%,以上睑下垂最常见(87.5%),碘-125使用和前部肿瘤位置是术后上睑下垂的独立危险因素。建议提高对这些并发症的认识并及时转诊至眼整形专科。
要点
- 巩膜敷贴放疗后IEDs发生率为20.9%,上睑下垂占IEDs的87.5%。
- 碘-125使用(OR 5.38)和前部肿瘤位置(OR 2.40)是术后上睑下垂的独立危险因素。
- 建议提高对IEDs的认识,并及时转诊至眼整形专科。
核心结论
- 获得性眼睑疾病尤其是上睑下垂是巩膜敷贴放疗后相对常见但未被充分认识并发症。
研究设计与样本
- 单中心回顾性临床队列研究,纳入2009至2023年接受巩膜敷贴放疗的患者191例,其中女性101例(52.9%),平均年龄63.4±14.2岁。
主要发现
- IEDs发生于40例(20.9%),主要累及上睑;上睑下垂35例(87.5%),良性眼睑病变3例(7.5%),倒睫1例(2.5%),睑外翻1例(2.5%)。
- 上睑下垂与前瞻肿瘤位置(p=0.03)、碘同位素(p=0.01)和女性性别(p=0.04)显著相关。
- 多因素logistic回归显示,碘-125使用(OR 5.38,95%CI 1.21-23.88;p=0.027)和前部肿瘤位置(OR 2.40,95%CI 1.01-5.71;p=0.048)与术后上睑下垂独立相关,女性性别未保持统计学显著性。
- 未发现与年龄、敷贴直径、辐射剂量、侧别、肌肉操作或睑缝合术的关联。
临床怎么用
- 对接受巩膜敷贴放疗的患者应提高对同侧获得性眼睑疾病的认识,尤其是上睑下垂。
- 发现眼睑异常时及时转诊至眼整形专科。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: While episcleral brachytherapy is an effective treatment for uveal melanoma, its long-term complications have primarily focused on intraocular structures. Eyelid disorders following brachytherapy are rarely reported despite potential complications related to the plaque surgery. This retrospective study aimed to assess the prevalence, characteristics, and risk factors for acquired ipsilateral eyelid disorders (IEDs) after ocular brachytherapy. DESIGN: A retrospective clinical cohort study was conducted on patients who underwent episcleral brachytherapy at a single tertiary center between 2009 and 2023. METHODS: Medical records were reviewed. Data collected included demographic variables, tumor characteristics, plaque type, surgical details, and presence of postoperative IEDs. The primary outcome was the association between brachytherapy and acquired IEDs. RESULTS: A total of 191 patients were included, 101 females (52.9%) mean age 63.4±14.2 years. All tumors were malignant melanoma: choroidal (n = 156, 81.7%), ciliary body (n = 27, 14.1%), iris (n = 7, 3.7%), and anterior segment (n = 1, 0.5%). Isotopes used included Iodine-125 (n = 150, 78.5%) and Ruthenium-106 (n = 41, 21.5%). IEDs developed in 40 cases (20.9%), predominantly affecting the upper eyelid. Ptosis was the most common finding (n = 35, 87.5%), followed by trichiasis (n = 1, 2.5%), ectropion (n = 1, 2.5%), and benign eyelid lesions (n = 3, 7.5%). Ptosis was significantly associated with anterior tumor location (p = 0.03), iodine isotope (p = 0.01), and female gender (p = 0.04). On multivariate logistic regression analysis, iodine-125 use (OR 5.38, 95% CI 1.21-23.88; p = 0.027) and anterior tumor location (OR 2.40, 95% CI 1.01-5.71; p = 0.048) remained independently associated with postoperative ptosis, whereas female gender did not retain statistical significance. No association was found with age, plaque diameter, radiation dose, laterality, muscle manipulation, or tarsorrhaphy. CONCLUSION: Acquired eyelid disorders, particularly upper eyelid ptosis, are a relatively common and underrecognized complication following episcleral brachytherapy. Increased awareness of these potential sequelae and timely referral to oculoplastic specialists are advised.
引用
- Madgar-Golfor S, Lustig Y, Nissan E, et al. Ipsilateral Eyelid Disorders Following Ocular Brachytherapy. Am J Ophthalmol. 2026. PMID: 42508709. doi:10.1016/j.ajo.2026.07.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。